Jazz Pharmaceuticals plc (JAZZ) Financials

JAZZ Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 11.2 billion 7.7 billion
2023-06-30 11.3 billion 7.7 billion
2023-03-31 11.0 billion 7.7 billion
2022-12-31 10.8 billion 7.7 billion

JAZZ Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 302.9 million 56.1 million
2023-06-30 291.0 million 61.4 million
2023-03-31 315.9 million 56.4 million
2022-12-31 -42.4 million 61.6 million

JAZZ Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 146.8 million
2023-06-30 104.4 million
2023-03-31 69.4 million
2022-12-31 -240.7 million

JAZZ Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.6 billion - 78.6 million
2023-06-30 1.4 billion 5.7 billion 82.5 million
2023-03-31 1.2 billion 5.7 billion 72.1 million
2022-12-31 881.5 million 5.7 billion 87.8 million

JAZZ Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 71.3 million
2023-06-30 73.5 million
2023-03-31 73.8 million
2022-12-31 63.1 million

JAZZ Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4.3 million 234.4 million 308.3 million -
2023-06-30 5.7 million 209.2 million 340.8 million -
2023-03-31 4.8 million 189.4 million 297.9 million -
2022-12-31 384.4 million 172.6 million 383.2 million -

JAZZ Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 972.1 million 102.2 million
2023-06-30 957.3 million 97.5 million
2023-03-31 892.8 million 128.6 million
2022-12-31 972.1 million 167.4 million

JAZZ

Price: $110.31

52 week price:
107.10
147.98

Payout Ratio Range:
2.89%
9.72%

Earnings Per Share: 6.10 USD

P/E Ratio: 144.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 468012

Ebitda: 136.8 million

Market Capitalization: 7.3 billion

Links: